FDAClass II · Medical device · Recall Z-1923-2026 · Recalled April 29, 2026

Oxoid Agglutinating Sera recall — Remel Europe Ltd.

Agency report date: April 29, 2026.

1. Compare your item

This notice names a product; your particular item is not yet verified. Compare every applicable model, serial, lot, production-date or model-year boundary below.

Product named: Oxoid Agglutinating Sera
Company / brand: Remel Europe
Lot / serial / date codes: UDI-DI 05056080500270 lots 6172600, 6172741, 6171393, 6150168, 6107767, 3766399, 3766400, 3780497, 3719592, 3709358, 6266130, 6253410, 6260215, 6222350, 6233859, 6233858
Distribution: Worldwide - US Nationwide distribution to the states of AL, CA, FL, IA, IL, IN, MI, MN, MO, NC, NE, OH, SD, TX, WA.

Agency product description and boundaries

Oxoid Agglutinating Sera, Salmonella 9-0 R30957301

Still to verify: match the label on your item with the full official notice, including any exclusions, tables and photos. Some identifiers appear only on the agency website and are absent from this data feed. A missing field does not mean all versions are affected.

If your lot or date falls outside a stated range, this notice has not established that your item is affected. This is not a finding about other recalls or product safety.

2. Agency hazard and consumer action

FDA reports: Affected lots are not performing to IFU criteria showing cross reactions with 2-0 within 60 seconds. Cross-reactivity may result in the misidentification of a Salmonella 9-O serotype as a 2-O serotype.

No consumer remedy instructions are supplied in this record. Check the official notice and listed company contact for the agency’s current instructions.

Class II: may cause temporary or medically reversible health consequences.

Affected product: Oxoid Agglutinating Sera

3. Open the official notice or contact

View the official FDA enforcement record (openFDA) ↗

Official recall ID: Z-1923-2026
Brand: Remel Europe
Classification: Class II
Units affected: 117 US; 950 OUS
Recall status: Ongoing
Initiated: Voluntary: Firm initiated

Affected products

Oxoid Agglutinating Sera

Companies & origin

Recalling firm location: Dartford, N/A, United Kingdom
Firm address: Clipper Boulevard West, Ken, N/A

Identifying details (verbatim from the notice)

Product codes / lots: UDI-DI 05056080500270 lots 6172600, 6172741, 6171393, 6150168, 6107767, 3766399, 3766400, 3780497, 3719592, 3709358, 6266130, 6253410, 6260215, 6222350, 6233859, 6233858
Distribution: Worldwide - US Nationwide distribution to the states of AL, CA, FL, IA, IL, IN, MI, MN, MO, NC, NE, OH, SD, TX, WA.
Firm notified the public via: Letter
FDA event ID: 98652
Recall initiated: March 25, 2026
FDA classified: April 22, 2026
FDA report date: April 29, 2026

Verify with the official sources:

CPSC — consumer products ↗ (aggregated here)
NHTSA — vehicles, car seats, tires ↗ (aggregated here; use NHTSA's VIN lookup to check a specific vehicle)
FDA — food, drugs, medical devices ↗ (aggregated here)
USDA FSIS — meat, poultry & processed egg products ↗ (not aggregated here)
Recalls.gov — the U.S. government’s all-agency portal ↗

Found something wrong or missing? Report a data error.

Source: U.S. Food & Drug Administration. Agency excerpts come from the public data feed and may omit tables or later changes; the linked government source is authoritative. Source last checked September 7, 2026 at 12:00 PM UTC. Record retrieved July 28, 2026 at 11:00 PM UTC.

Report a data error on this page